ARG70507

Human CD279 / PD-1 recombinant protein (His-tagged)

Human CD279 / PD-1 recombinant protein (His-tagged) for SDS-PAGE

概述

产品描述 CHO expressed, His-tagged Human CD279 / PD-1 recombinant protein.
应用 SDS-PAGE
靶点名称 CD279 / PD-1
物种 Human
A.A. 序列 Met1 - Gln167
表达系统 CHO
Protein Full name Programmed cell death protein 1
別名 PDCD1; Programmed Cell Death 1; PD1; CD279; HSLE1; PD-1; Systemic Lupus Erythematosus Susceptibility 2; Programmed Cell Death Protein 1; Protein PD-1; SLEB2; HPD-1; Programmed Cell Death 1 Protein; CD279 Antigen; HPD-L

属性

形式 Powder
纯化说明 Endotoxin level is less than 0.1 EU/µg of the protein, as determined by the LAL test.
纯度 > 95% (by SDS-PAGE)
缓冲液 PBS (pH 7.4)
复溶 It is recommended to reconstitute the lyophilized protein in 4 mM HCl to a concentration not less than 200 μg/mL and incubate the stock solution for at least 20 min at room temperature to make sure the protein is dissolved completely.
存放说明 For long term, lyophilized protein should be stored at -20°C or -80°C. After reconstitution, aliquot and store at -20°C or -80°C for up to one month. Storage in frost free freezers is not recommended. Avoid repeated freeze/thaw cycles. Suggest spin the vial prior to opening.
注意事项 For laboratory research only, not for drug, diagnostic or other use.

生物信息

基因名称 PDCD1
全名 Programmed Cell Death 1
背景介绍 Programmed cell death protein 1 (PDCD1) is an immune-inhibitory receptor expressed in activated T cells; it is involved in the regulation of T-cell functions, including those of effector CD8+ T cells. In addition, this protein can also promote the differentiation of CD4+ T cells into T regulatory cells. PDCD1 is expressed in many types of tumors including melanomas, and has demonstrated to play a role in anti-tumor immunity. Moreover, this protein has been shown to be involved in safeguarding against autoimmunity, however, it can also contribute to the inhibition of effective anti-tumor and anti-microbial immunity. [provided by RefSeq, Aug 2020]
生物功能 The blockage of the PDCD1-mediated pathway results in the reversal of the exhausted T-cell phenotype and the normalization of the anti-tumor response, providing a rationale for cancer immunotherapy. [Uniprot]